Skip to content

Intraoperative Fluid Management in Laparoscopic Bariatric Surgery

Intraoperative Fluid Management in Laparoscopic Bariatric Surgery - Does it Make a Difference?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00905502
Enrollment
107
Registered
2009-05-20
Start date
2007-04-30
Completion date
2008-12-31
Last updated
2009-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity, Acidosis, Intra-Abdominal Abscess, Hemorrhage, Reflux, Vomiting

Keywords

Obesity, fluid management, postoperative complications, bariatric surgery, hemostasis

Brief summary

The objective of this study is to evaluate the effects of 'high' versus 'low' volume intraoperative fluid administration (Ringer Lactate, RL) on intra- and postoperative parameters, in obese patients undergoing laparoscopic bariatric surgery (i.e., gastric bypass), in order to establish evidence-based data for perioperative fluid management in this patient population. Based on their experience as well as several reports in the literature, the investigators hypothesized that a restrictive approach to intraoperative hydration will reduce the incidence of postoperative complications and the recovery time of gastrointestinal (GI) function, and shorten hospital stay.

Detailed description

Obesity, a chronic disease that is increasing in prevalence in adults, adolescents, and children, is now considered to be a global epidemic. The prevalence of obesity has increased markedly in the last two decades and it is now considered to be a global epidemic. In the US 65% of all adults are overweight or obese and 30% are obese. Surgery is the only effective treatment for morbid obesity, and open Roux-en-Y gastric bypass (RYGB) has become the procedure of choice for these patients. Several studies on perioperative fluid management have reported that 'high volume' regimens may result in overhydration having deleterious effects on cardiac and pulmonary function, recovery of GI motility, tissue oxygenation, wound healing and coagulation. Most reported randomized trials suggest that perioperative fluid management has evolved to a more restricted regimen. Specifically, restricted fluid volumes applied during bariatric procedures have been shown to reduce perioperative complications (pulmonary dysfunction, hypoxia, nausea and vomiting), thereby decrease the prevalence of morbidity and mortality associated with such procedures. We wished to evaluate in a prospective randomized study the impact of fluid management on perioperative parameters in patients undergoing a variety of laparoscopic bariatric procedures: Roux-Y Gastric Bypass (LRYGB), Biliopancreatic Diversion with Duodenal Switch (LDS), or Sleeve Gastrectomy (LSG). Patients were randomly allocated to one of two groups receiving either 4 ml/kg•hr or 10 ml/kg•hr of RL solution throughout the intra-operative period. The primary endpoints of the study included: mortality rate and incidence of postoperative complications, during primary hospitalization. Readmission rate to the hospital within 30 days of surgery was another primary endpoint. The secondary endpoints included time till the patient resumed drinking and consuming soft food, length of hospital stay, differences in hematocrit, creatinine concentrations and oxygen saturation in the first and third postoperative days and with discharge, and the number of patients receiving transfusion of blood and blood products.

Interventions

Patients in the RG received 4 ml/kg•hr of Lactated Ringer's solution (RL) throughout the intra-operative period

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients ( \>18 years) with an American Society of Anesthesiology physical status of I-III who were presenting for laparoscopic bariatric surgery, were prospectively studied. * Patients were considered eligible if they had a BMI \> 40, or \> 35 and at least one comorbid condition and were scheduled to undergo one of the following laparoscopic operations: * Roux-Y Gastric Bypass (LRYGB) * Biliopancreatic Diversion with Duodenal Switch (LDS), or * Sleeve Gastrectomy (LSG).

Exclusion criteria

* Patients aged younger than 18 years. * Patients with renal dysfunction (creatinine \> 50% upper limit of normal value). * Congestive heart failure.

Design outcomes

Primary

MeasureTime frame
postoperative complications: mortality and morbidity (including readmissions)30 postoperative days (PODs)

Secondary

MeasureTime frame
GI recovery: time until the patient resumed drinking and consuming soft food3 PODs
length of hospital staypostoperative period
differences in hematocrit, creatinine concentrations and oxygen saturation in the first and third postoperative days and with dischargeprimary hospitalization
the number of patients receiving transfusion of blood and blood products3 PODs

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026